Gsk (GSK) Total Non-Current Liabilities (2009 - 2026)
Gsk (GSK) reported Total Non-Current Liabilities of -$43.16 billion for the quarter ended Sep 30, 2026, compared with -$32.59 billion a year earlier.
Gsk (GSK) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Gsk posted Total Non-Current Liabilities of $32.01 billion, up 3.4% from the prior year.
- Total Non-Current Liabilities has a five-year compound annual growth rate of -8.9% (years ended Dec 2020 to Dec 2025).
- By year, Total Non-Current Liabilities came in at $30.97 billion in the year ended Dec 31, 2024 (-3.3%), $32.02 billion in the year ended Dec 31, 2023 (-2.5%), $32.84 billion in the year ended Dec 31, 2022 (-28.6%) and $46.02 billion in the year ended Dec 31, 2021 (-9.9%).
- The figure for the quarter ended Sep 30, 2026 ranks as the lowest quarterly Total Non-Current Liabilities since the quarter ended Sep 30, 2021.
- Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at -$30.52 billion (quarter ended Jun 30, 2026), -$30.32 billion (quarter ended Mar 31, 2026) and $32.01 billion (quarter ended Dec 31, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Gsk | 100.27 Bn | 83.11 Bn | 8.73 Bn | -43.16 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -43.16 Bn |
| Jun 30, 2026 | -30.52 Bn |
| Mar 31, 2026 | -30.32 Bn |
| Dec 31, 2025 | 32.01 Bn |
| Sep 30, 2025 | -32.59 Bn |
| Jun 30, 2025 | -33.65 Bn |
| Mar 31, 2025 | -33.92 Bn |
| Dec 31, 2024 | 30.97 Bn |
| Sep 30, 2024 | -30.96 Bn |
| Jun 30, 2024 | -30.29 Bn |
| Mar 31, 2024 | -32.12 Bn |
| Dec 31, 2023 | 32.02 Bn |
| Sep 30, 2023 | -31.55 Bn |
| Jun 30, 2023 | -31.78 Bn |
| Mar 31, 2023 | -32.94 Bn |
| Dec 31, 2022 | 32.84 Bn |
| Sep 30, 2022 | -34.23 Bn |
| Jun 30, 2022 | -34.66 Bn |
| Mar 31, 2022 | -17.27 Bn |
| Dec 31, 2021 | 46.02 Bn |
Gsk Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();